OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.950
-0.020 (-1.02%)
Jul 29, 2026, 4:00 PM EDT - Market closed
[Name] Market Cap
OmniAb has a market cap or net worth of $282.7 million as of July 30, 2026. Its market cap has increased by 12.18% in one year.
Market Cap
282.70M
Enterprise Value
253.29M
1-Year Change
12.18%
Ranking
Category
Stock Price
1.95
ChartMarket Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $282.70M, a decrease of -71.53%. That is a compound annual growth rate of -28.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 282.70M | 6.15% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 309.70M |
| Neumora Therapeutics | 302.94M |
| Foghorn Therapeutics | 301.20M |
| Agenus | 286.86M |
| Opus Genetics | 280.72M |
| Bicycle Therapeutics | 275.06M |
| Immuneering | 269.79M |
| ALX Oncology Holdings | 269.13M |